9
Participants
Start Date
December 31, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
October 31, 2009
aplindore MR tablets or Placebo
aplindore MR tablets administered BID for about 13 weeks
Albany Medical College (037), Albany
University of Rochester (001), Rochester
University of Pennsylvania (018), Philadelphia
Duke University Medical Center (119), Durham
University of Miami (014), Miami
Parkinson's Disease & Movement Disorders Center of Boca Raton (196), Boca Raton
University of South Florida (019), Tampa
University of Alabama At Birmingham (052), Birmingham
University of Louisville (087), Louisville
University of Kentucky (172), Lexington
University of Cincinnati/Cincinnati Children's Hospital (089), Cincinnati
Medical College of Wisconsin (104), Milwaukee
Southern Illinois University (138), Springfield
Washington University (027), St Louis
Ochsner Clinic Foundation (207), New Orleans
LSU Health Science Center Shreveport (132), Shreveport
Baylor College of Medicine (007), Houston
Colorado Neurological Institute (052), Englewood
Mayo Clinic Arizona (060), Scottsdale
The Parkinson's Institute (012), Sunnyvale
Booth Gardner Parkinson's Care Center (220), Kirkland
Associated Neurologists, PC (190), Danbury
Eastern Connecticut Neurology Specialists (215), Manchester
Institute for Neurodegenerative Disorders (034), New Haven
Boston University (040), Boston
Lead Sponsor
Neurogen Corporation
INDUSTRY